Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth
Aleksandra Fesiuk(Christian Doppler Laboratory for Thermoelectricity), Lukas Kenner(University of Veterinary Medicine Vienna)
Cited by 0
Related Papers
PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas
|Nature Medicine|2012|125
The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
|Frontiers in Oncology|2020|113
Cell-autonomous GP130 activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0